Can fluoxetine (Prozac) cause overactive bladder symptoms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Prozac (Fluoxetine) Cause Overactive Bladder Symptoms?

Yes, fluoxetine (Prozac) can cause overactive bladder symptoms, with research demonstrating a significantly higher prevalence of OAB in antidepressant users compared to controls, and fluoxetine specifically showing the highest rate of OAB symptoms among SSRIs studied.

Evidence for Fluoxetine-Associated OAB

The most direct evidence comes from a prospective study that found:

  • The prevalence of OAB was 64% in antidepressant users versus 33% in healthy controls (p = 0.003) 1
  • Fluoxetine users had the highest prevalence of OAB at 63.6% among all SSRIs examined, compared to sertraline at 42.3% (p = 0.038) 1
  • Antidepressant users had significantly higher OAB-V8 scores compared to controls (p < 0.001) 1

Mechanism and Clinical Presentation

While the FDA label for Prozac does not specifically list OAB symptoms as a common adverse effect in its standard adverse reaction tables 2, the clinical evidence suggests this is a real phenomenon. The mechanism likely relates to:

  • Each SSRI has a unique pharmacological profile affecting bladder function differently 1
  • Fluoxetine can contribute to orthostatic hypotension, which may interact with bladder dysfunction 3
  • A case report documented severe bladder-related symptoms (micturition syncope) in a patient taking fluoxetine that resolved after discontinuation 3

Clinical Implications and Monitoring

Patients taking fluoxetine should be carefully monitored for OAB symptoms including:

  • Urinary urgency and frequency 1
  • Urgency urinary incontinence 1
  • Nocturia 1

Management Considerations

If OAB symptoms develop in a patient taking fluoxetine:

  • Consider switching to an alternative SSRI with lower OAB prevalence, such as sertraline (42.3% vs 63.6% for fluoxetine) 1
  • Evaluate for medication discontinuation or dose reduction if symptoms are bothersome, as demonstrated by symptom resolution after fluoxetine withdrawal 3
  • If continuing fluoxetine is necessary, standard OAB treatments can be initiated, including behavioral therapy, beta-3 agonists (preferred first-line), or antimuscarinic medications 4

Important Caveats

  • The association appears to be class-related but varies significantly between individual SSRIs 1
  • Patients with depression may have higher baseline OAB prevalence, making causality assessment challenging 1
  • The risk-benefit analysis must consider both the psychiatric indication for fluoxetine and the impact of OAB symptoms on quality of life 1

References

1
Research

Assessment of overactive bladder in women antidepressant users.

International urology and nephrology, 2015

Related Questions

Does Lexapro (escitalopram) cause over‑active bladder side effects?
Does Lexapro (escitalopram) cause overactive bladder symptoms?
Can antidepressant and antipsychotic medications cause new onset overactive bladder symptoms, and what is the recommended management?
Can overactive bladder symptoms persist two months after discontinuing tamoxifen?
Can escitalopram (Lexapro) cause new‑onset overactive bladder symptoms such as urinary urgency, frequency, or urge incontinence?
In an elderly patient with moderate leukocyturia and trace hematuria on urinalysis, presenting with cold-like symptoms, fatigue, increased sleep, and poor appetite, and already prescribed azithromycin for an upper respiratory infection, should I also start an antibiotic for a urinary tract infection?
What is the recommended starting adult dose of metoprolol succinate?
Is an ALS work‑up indicated for a patient without progressive asymmetric weakness, bulbar symptoms, fasciculations, hyperreflexia with muscle atrophy, and with a normal electromyography?
What does a high cortisol level indicate and how should it be confirmed, investigated, and managed?
Should an electromyography (EMG) be obtained now to exclude amyotrophic lateral sclerosis (ALS) in this patient?
Should an electromyography (EMG) with nerve‑conduction studies be performed now for a patient with progressive focal weakness, fasciculations, and possible upper‑motor‑neuron signs?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question